Afamelanotide + NB-UVB
Vitiligo
Clinical DevelopmentUnder Investigation
Key Facts
About Clinuvel Pharmaceuticals
Clinuvel Pharmaceuticals is a global leader in photomedicine, translating scientific expertise in melanocortins into therapeutic and cosmetic solutions. The company's core focus is on developing treatments for severe photodermatoses, vitiligo, and exploring applications in DNA repair and central nervous system disorders. With a commercial-stage product generating record revenues, Clinuvel is strategically expanding its pipeline and luxury skincare division, PhotoCosmetics, to leverage its proprietary science across multiple markets.
View full company profileTherapeutic Areas
Other Vitiligo Drugs
| Drug | Company | Phase |
|---|---|---|
| ZORYVE (roflumilast) Foam 0.3% | Arcutis Biotherapeutics | Phase 2 |